Sakar Healthcare Limited

NSEI:SAKAR Voorraadrapport

Marktkapitalisatie: ₹6.2b

Sakar Healthcare Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Sakar Healthcare heeft een totaal eigen vermogen van ₹2.7B en een totale schuld van ₹838.7M, wat de schuld-eigenvermogensverhouding op 31.1% brengt. De totale activa en totale passiva bedragen respectievelijk ₹4.0B en ₹1.3B. De EBIT Sakar Healthcare is ₹237.5M waardoor de rentedekking 4 is. Het heeft contanten en kortetermijnbeleggingen van ₹5.3M.

Belangrijke informatie

31.1%

Verhouding schuld/eigen vermogen

₹838.74m

Schuld

Rente dekkingsratio4x
Contant₹5.27m
Aandelen₹2.69b
Totaal verplichtingen₹1.35b
Totaal activa₹4.04b

Recente financiële gezondheidsupdates

Recent updates

Sakar Healthcare's (NSE:SAKAR) Anemic Earnings Might Be Worse Than You Think

Oct 30
Sakar Healthcare's (NSE:SAKAR) Anemic Earnings Might Be Worse Than You Think

Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?

Dec 28
Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?

Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?

Aug 05
Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?

Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?

Mar 29
Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?

Here's Why Sakar Healthcare (NSE:SAKAR) Has Caught The Eye Of Investors

Jan 31
Here's Why Sakar Healthcare (NSE:SAKAR) Has Caught The Eye Of Investors

Is Sakar Healthcare (NSE:SAKAR) Using Too Much Debt?

Dec 01
Is Sakar Healthcare (NSE:SAKAR) Using Too Much Debt?

Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet

Jul 13
Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet

Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet

Mar 26
Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet

With EPS Growth And More, Sakar Healthcare (NSE:SAKAR) Is Interesting

Jul 01
With EPS Growth And More, Sakar Healthcare (NSE:SAKAR) Is Interesting

Here's Why I Think Sakar Healthcare (NSE:SAKAR) Might Deserve Your Attention Today

Mar 23
Here's Why I Think Sakar Healthcare (NSE:SAKAR) Might Deserve Your Attention Today

Insider Buying: The Sakar Healthcare Limited (NSE:SAKAR) Chairman & MD Just Bought 7.1% More Shares

Mar 02
Insider Buying: The Sakar Healthcare Limited (NSE:SAKAR) Chairman & MD Just Bought 7.1% More Shares

Has Sakar Healthcare Limited's (NSE:SAKAR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Feb 08
Has Sakar Healthcare Limited's (NSE:SAKAR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?

Jan 10
Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?

Here's Why I Think Sakar Healthcare (NSE:SAKAR) Is An Interesting Stock

Dec 14
Here's Why I Think Sakar Healthcare (NSE:SAKAR) Is An Interesting Stock

Should You Rely On Sakar Healthcare's (NSE:SAKAR) Earnings Growth?

Nov 22
Should You Rely On Sakar Healthcare's (NSE:SAKAR) Earnings Growth?

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ₹804.5M ) SAKAR } overtreffen de korte termijn passiva ( ₹715.2M ).

Langlopende schulden: De kortetermijnactiva SAKAR ( ₹804.5M ) overtreffen de langetermijnschulden ( ₹632.9M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 30.9% ) SAKAR wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van SAKAR is de afgelopen 5 jaar gestegen van 15.4% naar 31.1%.

Schuldendekking: De schuld van SAKAR wordt goed gedekt door de operationele kasstroom ( 58.2% ).

Rentedekking: De rentebetalingen op de schuld van SAKAR worden goed gedekt door EBIT ( 4 x dekking).


Balans


Ontdek gezonde bedrijven